News
Cancer Horizons
All News
Blogs
Caregiving
Diet and Exercise
Financial
Psychosocial
Recipes
Sexual Health
Side Effect
Sponsored
Survivorship
Videos
All Videos
CURE Connections
CURE Expert Connections®
CURE Speaking Out
CURE TV
Educated Patient Sound Bites
On Demand: Award Programs
On Demand: Patient Summits
On Demand: Webinars
Conferences
Conference Coverage
Conference Listing
Events
CURE Adventures
CURE Awards
Educated Patient Summits & Updates
Educated Patient Webinars
Resources
Advocacy Groups
Art Gallery
CURE Ambassador Program
Clinical Trial Corner
Educated Patient Research Updates
Journey
Partners
Podcasts
Publications
Share Your Story
Subscribe
CURE Magazine
HEAL Magazine
Sign Up for eNews

logo
Spotlight
Blogs
Cancer Horizons
Clinical Trial Corner
Publications
Recipes
Videos
Cancer Type
Bladder
Breast
CLL
Kidney
Lung
MCL
Ovarian
Prostate
Skin
About CURE
Press Releases
Share Your Story
Write for CURE
Cancer Horizons
All News
Blogs
Caregiving
Diet and Exercise
Financial
Psychosocial
Recipes
Sexual Health
Side Effect
Sponsored
Survivorship
All Videos
CURE Connections
CURE Expert Connections®
CURE Speaking Out
CURE TV
Educated Patient Sound Bites
On Demand: Award Programs
On Demand: Patient Summits
On Demand: Webinars
Conference Coverage
Conference Listing
CURE Adventures
CURE Awards
Educated Patient Summits & Updates
Educated Patient Webinars
Advocacy Groups
Art Gallery
CURE Ambassador Program
Clinical Trial Corner
Educated Patient Research Updates
Journey
Partners
Podcasts
Publications
Share Your Story
CURE Magazine
HEAL Magazine
Sign Up for eNews
Advertisement
Bladder Cancer
| Brain Cancer
| Breast Cancer
| Childhood Cancers
| Gastric Cancer
| Gynecologic Cancer
| Head & Neck Cancer
| Immunotherapy
| Kidney Cancer
| Leukemia
| Liver Cancer
| Lung Cancer
| Lymphoma Cancer
| MDS
| MPN
| Melanoma
| Mesothelioma
| Myeloma
| Prostate Cancer
| Rare Cancers
| Sarcoma
| Skin Cancer
| Testicular Cancer
| Thyroid Cancer
| Waldenström Macroglobulinemia
View All >>
  • Bladder Cancer
  • Brain Cancer
  • Breast Cancer
  • Childhood Cancers
  • Gastric Cancer
  • Gynecologic Cancer
  • Head & Neck Cancer
  • Immunotherapy
  • Kidney Cancer
  • Leukemia
  • Liver Cancer
  • Lung Cancer
  • Lymphoma Cancer
  • MDS
  • MPN
  • Melanoma
  • Mesothelioma
  • Myeloma
  • Prostate Cancer
  • Rare Cancers
  • Sarcoma
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Waldenström Macroglobulinemia

SPOTLIGHT -

Blogs
| Cancer Horizons
| Clinical Trial Corner
| Publications
| Recipes
| Videos

FDA Issues Statement on New Cases of Rare Breast Implant-Related Cancers

September 9, 2022
Brielle Benyon
Article

The Food and Drug Administration issued a statement about the incidence of new cases of rare cancers that have occurred in the scar tissue around breast implants.

The Food and Drug Administration (FDA) issued a statement informing the public about cancers — specifically squamous cell carcinoma and lymphomas — that may occur in the scar tissue around breast implants.

Of note, these cancers are not the same as the previously reported breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), according to the agency.

According to the Skin Cancer Foundation, squamous cell carcinoma is the second most common form of skin cancer.

The FDA reported being aware of fewer than 20 cases of squamous cell carcinoma and fewer than 30 cases of different lymphomas found in the scar tissue around implants, known as the capsule. As of Sept. 1, there have been a total of 22 medical device reports (which monitor and report on potential safety issues from medical devices) for breast implants: 10 related to squamous cell carcinoma, and 12 related to lymphomas.

The incidence rate and risk factors for breast implant-related cancers are currently unknown, according to the FDA.

“When breast implant information was provided, there have been literature reports of (squamous cell carcinoma) and various lymphomas in the capsule around the breast implants for both textured and smooth breast implants, and for both saline and silicone breast implants,” the FDA wrote in their report. “In some cases, people were diagnosed after years of having breast implants. Some of the reported signs and symptoms included swelling, pain, lumps or skin changes.”

Recommendations for Individuals With or Considering Breast Implants

The FDA recommended that people with breast implants, or those who are considering them should learn more about the potential risks.

Those who already have implants do not need to change their medical care, according to the agency, though they should monitor their implants and talk to their surgeons or health care team if they notice any changes. At this time, the FDA is not recommending the removal of implants for women without symptoms.

For women who experience issues or symptoms from their implants, the FDA urges them to file a report through MedWatch, which is the agency’s way of collecting data on side effects, which can potentially improve patient safety.

In the future, the FDA noted that it plans to complete a literature review of data and continue its partnership with the American Society of Plastic Surgeons to gather more information about cancers arising in the breast capsule. These findings will be communicated to the public.

“Right now, we do not have enough information to say whether breast implants cause these cancers or if some implants pose higher risks than others,” the FDA said in a statement. “For this reason, instances of (squamous cell carcinoma), lymphoma and any cancer located in the scar tissue around breast implants should be reported to the FDA.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Juanita Miller
Dr. Manisha Thakuria in an interview with CURE
Dr. Beth Goldstein in an interview with CURE
Related Content

Second Remission Likely After Retreatment With Keytruda for Patients with Hodgkin Lymphoma

October 2nd 2023

Author, Five-Time Cancer Survivor Shares His Experiences in New Book

August 10th 2023

Tailoring Breast Cancer Treatment: The Role of Genomic Testing

October 1st 2023

Latinas Contra Cancer ‘Holds Space for Patients to Become Powerful’

July 13th 2023

Increasing Awareness Around Inflammatory Breast Cancer

September 30th 2023

Cancer Conversation

September 29th 2023

Second Remission Likely After Retreatment With Keytruda for Patients with Hodgkin Lymphoma

October 2nd 2023

Author, Five-Time Cancer Survivor Shares His Experiences in New Book

August 10th 2023

Tailoring Breast Cancer Treatment: The Role of Genomic Testing

October 1st 2023

Latinas Contra Cancer ‘Holds Space for Patients to Become Powerful’

July 13th 2023

Increasing Awareness Around Inflammatory Breast Cancer

September 30th 2023

Cancer Conversation

September 29th 2023

Second Remission Likely After Retreatment With Keytruda for Patients with Hodgkin Lymphoma

October 2nd 2023

Author, Five-Time Cancer Survivor Shares His Experiences in New Book

August 10th 2023

Tailoring Breast Cancer Treatment: The Role of Genomic Testing

October 1st 2023

Latinas Contra Cancer ‘Holds Space for Patients to Become Powerful’

July 13th 2023

Increasing Awareness Around Inflammatory Breast Cancer

September 30th 2023

Cancer Conversation

September 29th 2023
Related Content
Advertisement

Second Remission Likely After Retreatment With Keytruda for Patients with Hodgkin Lymphoma

Second Remission Likely After Retreatment With Keytruda for Patients with Hodgkin Lymphoma

October 2nd 2023
Article

A phase 2 trial found that some patients with classical Hodgkin lymphoma saw a nearly 74% probability of second remission due to retreatment with Keytruda.

Read More


Bill C. Potts holding his small dog, Pippa | Photo credit: Sarah Potts

Author, Five-Time Cancer Survivor Shares His Experiences in New Book

August 10th 2023
Podcast

Bill C. Potts, author and five-time cancer survivor, lends his experience and tips about cancer to others in his book, “Up for the Fight.”

Listen


Tailoring Breast Cancer Treatment: The Role of Genomic Testing

Tailoring Breast Cancer Treatment: The Role of Genomic Testing

October 1st 2023
Article

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about personalized therapy in breast cancer care.

Read More


Darcie Green, executive director of Latinas Contra Cancer |  Photos courtesy of Helynn Ospina

Latinas Contra Cancer ‘Holds Space for Patients to Become Powerful’

July 13th 2023
Podcast

Darcie Green, executive director of service and advocacy organization Latinas Contra Cancer, tells the CURE® “Cancer Horizon” podcast about how its work has broadened over the last 20 years.

Listen


Increasing Awareness Around Inflammatory Breast Cancer

Increasing Awareness Around Inflammatory Breast Cancer

September 30th 2023
Article

A woman with stage 4 inflammatory breast cancer details her journey with the disease and why it is important for patients to ask questions about anything going on with their bodies.

Read More


Cancer Conversation

Cancer Conversation

September 29th 2023
Article

Back 50 years or so ago, people didn’t discuss cancer freely. Today, things have changed.

Read More

About
Advertise / Support
Contact
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.